Search Within

Viktoriya Paroder

  1. "Geoffrey Ku"
Formats
  1. Journal Article (5)
  2. Meeting Abstract (4)
  3. Review (1)
Groups
  1. Body Imaging Service (10)
  2. Department of Medicine (10)
  3. Gastrointestinal Oncology Service (10)
  4. Hematologic Malignancies, Division of (10)
  5. Radiology, Department of (10)
  6. Solid Tumor Oncology Division (10)

More Groups

People
  1. Geoffrey Ku (10)
  2. Steven Maron (7)
  3. Yelena Janjigian (7)
  4. Joanne Chou (6)
  5. Marinela Capanu (6)
  6. David Ilson (5)

More People

Years
  1. 2024 (2)
  2. 2023 (2)
  3. 2022 (2)
  4. 2021 (1)
  5. 2020 (2)
  6. 2019 (1)
Publications
  1. Journal of Clinical Oncology (3)
  2. American Journal of Roentgenology (1)
  3. Annals of Oncology (1)
  4. Cancers (1)
  5. Clinical Cancer Research (1)
  6. Journal of Gastrointestinal Oncology (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (3)
  2. American Association for Cancer Research (1)
  3. American Roentgen Ray Society (1)
  4. Elsevier Science, Inc. (1)
  5. MDPI (1)
  6. Oxford University Press (1)

More Publishers

Results (10)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Noninvasive assessment of programmed-death ligand-1 (PD-L1) in esophagogastric (EG) cancer using (18)F-BMS-986229 PET
    Meeting Abstract

    Cytryn, S. L.; Pandit-Taskar, N.; Maron, S. B.; Gu, P.; Ku, G. Y.; Chou, J. F.; Capanu, M.; Feder, L.; Philemond, S.; Lyashchenko, S. K.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • (18)F-BMS-986229 PET to assess programmed-death ligand 1 status in gastroesophageal cancer
    Journal Article

    Cytryn, S. L.; Pandit-Taskar, N.; Lumish, M. A.; Maron, S. B.; Gu, P.; Ku, G. Y.; Chou, J. F.; Capanu, M.; Antoine, A.; Loegel, D.; more...
    Journal of Nuclear Medicine (2024)

    Fulltext@MSK | Save
  • First-line regorafenib with nivolumab and chemotherapy in advanced oesophageal, gastric, or gastro-oesophageal junction cancer in the USA: A single-arm, single-centre, phase 2 trial
    Journal Article

    Cytryn, S. L.; Moy, R. H.; Cowzer, D.; Shah, R. H.; Chou, J. F.; Joshi, S. S.; Ku, G. Y.; Maron, S. B.; Desai, A.; Yang, J.; more...
    Lancet Oncology (2023)

    Fulltext@MSK | Save
  • Determinants of survival with combined HER2 and PD-1 blockade in metastatic esophagogastric cancer
    Journal Article

    Maron, S. B.; Chatila, W.; Walch, H.; Chou, J. F.; Ceglia, N.; Ptashkin, R.; Do, R. K. G.; Paroder, V.; Pandit-Taskar, N.; Lewis, J. S.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • Regorafenib (REGO) with nivolumab (NIVO) and FOLFOX in HER2 negative esophagogastric cancer (EGC)
    Meeting Abstract

    Cytryn, S.; Joshi, S.; Ku, G. Y.; Maron, S. B.; Desai, A.; Yang, J.; Rao, D.; Goldberg, Z.; Sugarman, R.; Antoine, A.; more...
    Annals of Oncology (2022)

    Fulltext@MSK | Save
  • Can (18)F-FDG PET/CT radiomics features predict clinical outcomes in patients with locally advanced esophageal squamous cell carcinoma?
    Journal Article

    Jayaprakasam, V. S.; Gibbs, P.; Gangai, N.; Bajwa, R.; Sosa, R. E.; Yeh, R.; Greally, M.; Ku, G. Y.; Gollub, M. J.; Paroder, V.
    Cancers (2022)

    Fulltext@MSK | Save
  • Early predictors of benefit to dual anti-PD1/HER2 inhibition: Biomarker analysis from phase 2 trial of pembrolizumab/trastuzumab in HER2-positive metastatic esophagogastric (mEG) cancer
    Meeting Abstract

    Maron, S. B.; Chatila, W. K.; Walch, H. S.; Ptashkin, R.; Sabwa, S.; Ling, L.; Nagy, R.; Simmons, M.; Do, R. K. G.; Paroder, V.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Role of imaging in esophageal cancer management in 2020: Update for radiologists
    Review

    Jayaprakasam, V. S.; Yeh, R.; Ku, G. Y.; Petkovska, I.; Fuqua, J. L. 3rd; Gollub, M.; Paroder, V.
    American Journal of Roentgenology (2020)

    Fulltext@MSK | Save
  • Pembrolizumab with trastuzumab and chemotherapy (PTC) in HER2-positive metastatic esophagogastric cancer (mEG): Plasma and tumor-based biomarker analysis
    Meeting Abstract

    Maron, S. B.; Chatila, W. K.; Millang, B. M.; Sabwa, S.; Chou, J. F.; Ling, L.; Nagy, R.; Simmons, M.; Do, R. K. G.; Paroder, V.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Maximizing response: A case report of salvage chemotherapy after immune checkpoint inhibition in a patient with previous chemo-refractory metastatic esophageal carcinoma
    Journal Article

    Greally, M.; Agarwal, R.; El Dika, I.; Shamseddine, A.; El-Olayan, A.; Haibe, Y.; Paroder, V.; Shia, J.; Abou-Alfa, G. K.; Ku, G. Y.
    Journal of Gastrointestinal Oncology (2019)

    Fulltext@MSK | Save